West Bengal Governor Jagdeep Dhankhar today inaugurated the launch of Phase-3 regulatory trial of Covaxin at ICMR-NICED in Kolkata, lauding the country's leadership for "effectively tackling" the COVID-19 pandemic.
Mr Dhankhar said NICED (National Institute of Cholera and Enteric Diseases) has been chosen as one among two dozen centres in the country for the third phase trial of the indigenously developed coronavirus vaccine, and expressed confidence that the procedure would be conducted smoothly.
"India has done commendably well (when it comes to handling the pandemic). It is all on account of the country's visionary leadership," he said.
The governor further said that the Centre's Ayushman Bharat scheme, which provides free healthcare services, has provided help to many amid the crisis.
Notably, the scheme has not been implemented in West Bengal so far.
The Trinamool Congress government had said in September that it would implement the scheme if funds for the programme are routed through the state administration, contrary to the provisions laid down by the Centre.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
Top Medical Body Slams Study On Covaxin Safety, Side-Effects, Wants Apology Covaxin Has Excellent Safety Record: Bharat Biotech On Study Citing Risks No Side Effects From Our Vaccine: Covaxin Maker Amid AstraZeneca Row "Took Advantage Of His Addiction": 5 Charged Over Matthew Perry's Death Nurse Raped, Killed On Way Home, Body Found 9 Days Later In UP "Don't Expect Anything From Me": Kolkata Hospital's New Principal Loses Cool Ukraine, Russia Both Claim Advances In Kursk Region Gaza Ceasefire Talks Underway In Qatar As Deaths Top 40,000 Trump To Hold Press Conference, His Campaign Adds Senior Advisers Track Latest News Live on NDTV.com and get news updates from India and around the world.